Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study-Reference-Cited by-同舟云学术

Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study

Published:2020-04-21 Issue:7 Volume:95 Page:766-774
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Nouraie Mehdi¹,Darbari Deepika S.²^ORCID,Rana Sohail³,Minniti Caterina P.⁴^ORCID,Castro Oswaldo L.³,Luchtman‐Jones Lori⁵,Sable Craig²,Dham Niti²,Kato Gregory J.¹^ORCID,Gladwin Mark T.¹,Ensing Gregory⁶,Arteta Manuel⁷,Campbell Andrew²^ORCID,Taylor James G.³^ORCID,Nekhai Sergei³^ORCID,Gordeuk Victor R.⁸^ORCID

Affiliation:

1. University of Pittsburgh Pittsburgh Pennsylvania USA

2. Children's National Medical Center Washington District of Columbia USA

3. Center for Sickle Cell DiseaseHoward University Washington District of Columbia USA

4. Montfiore Medical Center, Einstein College of Medicine New York New York USA

5. Cincinnati Children's Hospital Medical Center/University of Cincinnati College of Medicine Cincinnati Ohio USA

6. University of Michigan Ann Arbor Michigan USA

7. Mayo Clinic Rochester Minnesota USA

8. University of Illinois at Chicago Chicago Illinois USA

Funder

National Institutes of Health

Publisher